Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 77.00% is 118% above its 5-year average of 35.27%, near the high end of its 5-year range (16.23%–85.56%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.85% above its 12-month average of 72.07%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 77.00%.
RETURN ON INVESTED CAPITAL (ROIC)
77.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
72.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
50.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
35.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
23.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.85%
CURRENT VS 3Y AVG
+51.74%
CURRENT VS 5Y AVG
+118.31%
CURRENT VS 10Y AVG
+223.95%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+780.53%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$17.17B
Return on Invested Capital (ROIC)
77.00%
TTM Avg
72.07%
3Y Avg
50.75%
5Y Avg
35.27%
Market Cap
$16.37B
Return on Invested Capital (ROIC)
2.91%
TTM Avg
2.97%
3Y Avg
3.43%
5Y Avg
5.52%
Market Cap
$18.23B
Return on Invested Capital (ROIC)
5.51%
TTM Avg
5.58%
3Y Avg
5.01%
5Y Avg
4.00%
Market Cap
$15.16B
Return on Invested Capital (ROIC)
15.85%
TTM Avg
12.30%
3Y Avg
11.68%
5Y Avg
11.64%
Market Cap
$14.70B
Return on Invested Capital (ROIC)
37.87%
TTM Avg
23.96%
3Y Avg
17.78%
5Y Avg
13.78%
Market Cap
$19.95B
Return on Invested Capital (ROIC)
-0.29%
TTM Avg
-4.13%
3Y Avg
-1.14%
5Y Avg
-0.84%
Market Cap
$14.08B
Return on Invested Capital (ROIC)
-14.34%
TTM Avg
-61.05%
3Y Avg
-59.83%
5Y Avg
-54.60%
Market Cap
$20.28B
Return on Invested Capital (ROIC)
8.74%
TTM Avg
7.84%
3Y Avg
7.14%
5Y Avg
6.51%
Market Cap
$13.57B
Return on Invested Capital (ROIC)
7.72%
TTM Avg
5.13%
3Y Avg
6.33%
5Y Avg
6.84%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.17B | 77.00% | 72.07% | 50.75% | 35.27% |
| Revvity, Inc. (RVTY)vs › | $16.37B | 2.91% | 2.97% | 3.43% | 5.52% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.23B | 5.51% | 5.58% | 5.01% | 4.00% |
| Solventum Corporation (SOLV)vs › | $15.16B | 15.85% | 12.30% | 11.68% | 11.64% |
| Exelixis, Inc. (EXEL)vs › | $14.70B | 37.87% | 23.96% | 17.78% | 13.78% |
| Viatris Inc. (VTRS)vs › | $19.95B | -0.29% | -4.13% | -1.14% | -0.84% |
| Tempus AI, Inc. (TEM)vs › | $14.08B | -14.34% | -61.05% | -59.83% | -54.60% |
| STERIS plc (STE)vs › | $20.28B | 8.74% | 7.84% | 7.14% | 6.51% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.57B | 7.72% | 5.13% | 6.33% | 6.84% |
| United Therapeutics Corporation (UTHR)vs › | $21.11B | 17.69% | 15.79% | 14.57% | 13.09% |
ROIC
77.0%
ROE
113.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 77.00% |
| 2026-03-31 | 57.77% |
| 2025-12-31 | 67.94% |
| 2025-09-30 | 85.56% |
| 2025-03-31 | 50.93% |
| 2024-12-31 | 38.11% |
| 2024-09-30 | 33.13% |
| 2024-06-30 | 35.21% |
| 2024-03-31 | 36.45% |
| 2023-12-31 | 38.78% |
| 2023-09-30 | 43.79% |
| 2023-06-30 | 44.29% |
| 2023-03-31 | 40.48% |
| 2022-12-31 | 40.36% |
| 2022-09-30 | 33.97% |
| 2022-06-30 | 29.86% |
| 2022-03-31 | 25.72% |
| 2021-12-31 | 16.23% |
| 2021-09-30 | 17.07% |
| 2021-06-30 | 17.48% |
| 2021-03-31 | 15.78% |
| 2020-12-31 | 15.16% |
| 2020-09-30 | 13.09% |
| 2020-06-30 | 12.01% |
| 2020-03-31 | 13.81% |
| 2019-12-31 | 12.80% |
| 2019-09-30 | 12.73% |
| 2019-06-30 | 12.83% |
| 2019-03-31 | 11.10% |
| 2018-12-31 | 11.07% |
| 2018-09-30 | 9.42% |
| 2018-06-30 | 7.78% |
| 2018-03-31 | 6.78% |
| 2017-12-31 | 5.75% |
| 2017-09-30 | 5.03% |
| 2017-06-30 | 4.49% |
| 2017-03-31 | 4.15% |
| 2016-12-31 | 3.90% |
| 2016-09-30 | 2.60% |
| 2016-06-30 | 2.17% |
| 2016-03-31 | 3.16% |
| 2015-12-31 | 2.42% |
